Form 4: Avid Bioservices CEO Nicholas Green Acquires Shares Through Employee Stock Purchase Plan
SEC Form 4
Nicholas Green, President & CEO of Avid Bioservices, Inc., acquired 1,965 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a price of $5.406 per share on June 28, 2024.
Summary
- On June 28, 2024, Nicholas Green, the President and CEO of Avid Bioservices, Inc., acquired 1,965 shares of the company's common stock.
- The shares were purchased through the Employee Stock Purchase Plan (ESPP) at a price of $5.406 per share.
- This transaction increased Green's direct ownership to 205,571 shares.
- The ESPP offering period was from January 1, 2024, through June 30, 2024.
- The purchase price was 85% of the closing price of Avid Bioservices' common stock on January 2, 2024.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The CEO's participation in the ESPP is a good sign, but the filing itself is a routine disclosure.
Positives
- The CEO's participation in the ESPP demonstrates confidence in the company's future.
- The ESPP provides employees with an opportunity to invest in the company's stock at a discounted price.
Industry Context
This filing is a routine disclosure related to insider transactions and is common for publicly traded companies with employee stock purchase plans. It reflects standard practice for executives to participate in such plans.
Comparison to Industry Standards
- Employee Stock Purchase Plans (ESPPs) are a common benefit offered by publicly traded companies, including those in the biotechnology and pharmaceutical sectors.
- Companies like Amgen, Biogen, and Gilead also offer ESPPs to their employees, typically with similar discount structures (e.g., 15% discount).
- Executive participation in ESPPs is generally viewed positively, aligning their interests with those of shareholders.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the CEO's interests with theirs.
- Employees participating in the ESPP benefit from the discounted stock purchase.
Key Dates
| Date | Description |
|---|---|
| January 1, 2024 | Start of the ESPP offering period. |
| January 2, 2024 | Date used to determine the purchase price of shares under the ESPP (85% of the closing price). |
| June 28, 2024 | Date of the transaction where Nicholas Green acquired shares. |
| June 30, 2024 | End of the ESPP offering period. |
| July 02, 2024 | Date of the form filing. |
Keywords
Avid Bioservices, Nicholas Green, ESPP, Employee Stock Purchase Plan, Common Stock, Beneficial Ownership, CDMO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.